HEALIUS LIMITED — Director's Dealing 2022

Sep 4, 2022

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entityHEALIUS LIMITED**(Company)**	Name of entityHEALIUS LIMITED**(Company)**
ABN	24 064 530 516

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Malcolm Parmenter
Date of last notice	5 July 2022 (correction issued 1 September 2022)

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [434 x 328] intentionally omitted <==

----- Start of picture text ----- Direct or indirect interest DirectAs shown in relation to Ordinary SharesNature of indirect interest(including registered holder) Not applicable in relation to Performance RightsNote: Provide details of the circumstances givingrise to the relevant interest. Not applicable in relation to OptionsDate of change 2 September 2022Malcolm W Parmenter Pty Ltd59,597atf Malcolm W ParmenterOrdinary SharesSuperannuation FundNo. of securities held prior to 722,961Malcolm Parmenterchange Ordinary Shares11,081,391Malcolm ParmenterOptionsClass Fully paid Ordinary SharesNumber acquired 617,779 Ordinary SharesNumber disposed 3,693,797 Options----- End of picture text -----

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/ConsiderationNote: If consideration is non-cash, provide detailsand estimated valuation	$3.05 exercise price per Option; 3,656,859 Optionsexercised for total exercise price of $11,153,420(cashless exercise mechanism used)
	59,597Ordinary sharesMalcolm W Parmenter Pty Ltdatf Malcolm W ParmenterSuperannuation Fund
No. of securities held afterchange	1,340,740Ordinary sharesMalcolm Parmenter
	7,387,594OptionsMalcolm Parmenter
	Issue of 617,779 fully paid Ordinary Shares on exercise
	of 3,656,859 vested Tranche 1 Options under FY 2020
	Transformation Long-Term Incentive Plan (date of
	shareholder approval 25 November 2019; date of award
	03 March 2020; exercise date 31 August 2022).
Nature of changeExample: on-market trade, off-market trade,exercise of options, issue of securities under	Current Market Price of $3.67 (HLS close price on 1September 2022) used in cashless exercise mechanism
dividend reinvestment plan, participation in buy-back	for net 617,779Ordinary Shares issued.
	36,938 unvested Tranche 1 Options lapsed.
	Tranches 2 & 3 Options (total 7,387,594 Options) remain
	on foot for performance testing at the end of FY 2023
	andFY 2024 respectively.

Part 2 – Change of director’s interests in contracts Not applicable

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contractsdetailed above traded during a+closed period whereprior written clearance was required?	Not applicable
If so, was prior written clearance provided to allow thetrade to proceed during this period?	Not applicable
If prior written clearance was provided, on what datewas this provided?	Not applicable

Authorised by the Company Secretary

Charles Tilley Company Secretary

Date: 5 September 2022

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011